GB Sciences Granted US Patent for Cannabinoid-based Formulations for Parkinson’s

GB Sciences Granted US Patent for Cannabinoid-based Formulations for Parkinson’s
GB Sciences has been granted a patent from the U.S. Patent and Trademark Office (USPTO) covering the use of its proprietary cannabinoid-containing complex mixtures for treating Parkinson’s disease, the company announced. GB Sciences is creating a pipeline of new medicines based on cannabinoids, the pharmacologically active compounds that give the cannabis plant its medical and recreational properties. The patent — number 10,653,640 ... read more
Source: Parkinson’s News TodayPublished on 2020-05-07By Patricia Inacio, PhD